These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2004454)

  • 21. Radioimmunoassay of drugs subject to abuse: critical evaluation of urinary morphine-barbiturate, morphine, barbiturate, and amphetamine assays.
    Mulé SJ; Whitlock E; Jukofsky D
    Clin Chem; 1975 Jan; 21(1):81-6. PubMed ID: 1116282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the EMIT-(TM) technique as a screening test for opiates and methadone for a methadone maintenance clinic and its calibration by Bayesian statistics.
    Cavanagh K; Draisey TF; Thibert RJ
    Clin Biochem; 1978 Oct; 11(5):210-3. PubMed ID: 365392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid horizontal TLC method for detecting drugs of abuse.
    Wolff K; Sanderson MJ; Hay AW
    Ann Clin Biochem; 1990 Sep; 27 ( Pt 5)():482-8. PubMed ID: 2281929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops.
    Pearson SD; Ash KO; Urry FM
    Clin Chem; 1989 Apr; 35(4):636-8. PubMed ID: 2467764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
    Carlsson S; Olsson R; Lindkvist I; Beck O
    Scand J Clin Lab Invest; 2015 Apr; 75(2):156-61. PubMed ID: 25562730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the use of XAD-2 resin for detection of abused drugs in urine.
    Kullberg MP; Gorodetzky CW
    Clin Chem; 1974 Feb; 20(2):177-83. PubMed ID: 4812991
    [No Abstract]   [Full Text] [Related]  

  • 27. Fallibility of urine drug screens in monitoring methadone programs.
    Gottheil E; Caddy GR; Austin DL
    JAMA; 1976 Aug; 236(9):1035-8. PubMed ID: 989579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of certain drugs of abuse in urine specimens.
    Frings CS; Queen CA
    Clin Chem; 1972 Nov; 18(11):1442. PubMed ID: 4652848
    [No Abstract]   [Full Text] [Related]  

  • 29. Simple gas-liquid chromatographic method for confirming the presence of alkaloids in urine.
    Sine HE; Kubasik NP; Woytash J
    Clin Chem; 1973 Mar; 19(3):340-1. PubMed ID: 4689105
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Bionike one-step tests for the detection of drugs of abuse in urine.
    Brown ER; Jarvie DR; Simpson D
    Ann Clin Biochem; 1997 Jan; 34 ( Pt 1)():74-80. PubMed ID: 9022891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous detection of a wide variety of commonly abused drugs in a urine screening program using thin-layer identification techniques.
    Kaistha KK; Tadrus R; Janda R
    J Chromatogr; 1975 Apr; 107(2):359-79. PubMed ID: 1137995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of fluorescamine ("Fluram") to detect amphetamine in urine by thin-layer chromatography.
    Klein B; Sheehan JE; Grunberg E
    Clin Chem; 1974 Feb; 20(2):272-4. PubMed ID: 4813005
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of cocaethylene, benzoylecgonine and cocaine in human urine by high-performance thin-layer chromatography with ultraviolet detection: a comparison with high-performance liquid chromatography.
    Antonilli L; Suriano C; Grassi MC; Nencini P
    J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):19-27. PubMed ID: 11232850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunuassay compared to thin-layer and gas--liquid chromatography for detecting methadone in human urine.
    Roerig DL; Wang RI; Mueller MM; Lewand DL; Adams SM
    Clin Chem; 1976 Nov; 22(11):1915-8. PubMed ID: 975556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific conductivity of urine and sensitivity of enzyme immunoassay methods of analysis for drugs of abuse.
    Anderson O; Eriksen PB
    Clin Chem; 1977; 23(4):751-3. PubMed ID: 321149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of extraction techniques for drugs of abuse in urine.
    Wilson JF; Smith BL; Toseland PA; Watson ID; Williams J; Thomson AH; Capps NE; Sweeney G; Sandle LN;
    Forensic Sci Int; 2001 Jun; 119(1):23-7. PubMed ID: 11348790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confirmed identification of biotransformed drugs of abuse in urine.
    Baden MM; Valanju NN; Verma SK; Valanju SN
    Am J Clin Pathol; 1972 Jan; 57(1):43-51. PubMed ID: 5008893
    [No Abstract]   [Full Text] [Related]  

  • 40. Thin-layer chromatographic screening and confirmation of basic drugs of abuse in urine.
    Jain NC; Leung WJ; Budd RD; Sneath TC
    J Chromatogr; 1975 Dec; 115(2):519-26. PubMed ID: 1206062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.